AVID RADIOPHARMACEUTICALS, INC.
- Headquarters
- PHILADELPHIA, PA
- Founded
- 2004
- Latest Form D
- $28.5M, May 2009
- Total capital
- $31M
- Federal grants
- $2.5M
- 11 awards · 2005–2008
- Private capital raised
- $28.5M
- 1 Form D · last May 2009
- 209 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 7 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$28.5M
- Federal grantHealth and Human S · Phase I · 18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment$250K
- Federal grantHealth and Human S · Phase I · 18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment$257K
- Federal grantHealth and Human S · Phase I · Development of Radiopharmaceuticals for Imaging Brain Tau Pathology$249K
- Federal grantHealth and Human S · Phase I · Development of Radiopharmaceuticals for Imaging Brain Tau Pathology$249K
- Federal grantHealth and Human S · Phase I · 18F-AV-133, A Novel Radiopharmaceutical for Differential Diagnosis of Dementia$249K
- Federal grantHealth and Human S · Phase I · 18F-AV-133, A Novel Radiopharmaceutical for Differential Diagnosis of Dementia$249K
Show 5 earlier federal awards
- Federal grantHealth and Human S · Phase I · Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's$250K
- Federal grantHealth and Human S · Phase I · Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's$250K
- Federal grantHealth and Human S · Phase I · 18F-FP-DTBZ for PET Imaging of Beta Cell Mass in Diabetes$247K
- Federal grantHealth and Human S · Phase I · AV1: F-18 Radiopharmaceutical for Imaging Amyloid Plaque$100K
- Federal grantHealth and Human S · Phase I · Radiopharmaceuticals for Imaging Brain Synuclein$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
45months
from AVID RADIOPHARMACEUTICALS, INC.’s first federal award to its first private round.
- First federal award · Sep 2005
- Health and Human S · $100K
- First Form D · May 2009
- $28.5M · 1st Form D
- Awards before first raise
- 11 awards
An association in public records, not a cause or a prediction.
Founders and team
Researcher links verified by same-company patents and grants- Daniel M. SkovronskyResearcherExecutive Officer, DirectorLinked by $1.4M in grants as PI
- Alan P. CarpenterExecutive OfficerNamed in SEC Form D filings
- Edward M. HurwitzDirectorNamed in SEC Form D filings
- Ernest MarioDirectorNamed in SEC Form D filings
- Gary J. KurtzmanDirectorNamed in SEC Form D filings
- Matthew P. Rhodes-KropfDirectorNamed in SEC Form D filings
Show all 8 people
- Richard A. BaronExecutive OfficerNamed in SEC Form D filings
- William A. HamiltonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 7- PendingRadiopharmaceutical Imaging Of Neurodegenerative DiseasesUSPTOApplication 14053382
- PendingSynthesis Of 18F-RADIOLABELED Styrylpyridines From Tosylate Precursors And Stable Pharmaceutical Compositions ThereofUSPTOApplication PCTUS2009069741
- PendingPsma Targeted Reversed Carbamates And Methods Of Use ThereofUSPTOApplication PCTUS2015056914
Show all 7 patent records
- Radiopharmaceutical Imaging Of Neurodegenerative DiseasesFeb 13, 2014 · Application 14053382Pending
- Synthesis Of 18F-RADIOLABELED Styrylpyridines From Tosylate Precursors And Stable Pharmaceutical Compositions ThereofApplication PCTUS2009069741Pending
- Psma Targeted Reversed Carbamates And Methods Of Use ThereofApplication PCTUS2015056914Pending
- Radiopharmaceutical Imaging Of Neurodegenerative DiseasesApplication PCTUS2009039511Pending
- Gamma Probe Detection Of Amyloid Plaque Using Radiolabeled A-beta Binding CompoundsApplication PCTUS2009034886Pending
- Halo-stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid PlaquesApplication PCTUS2008060149Pending
- Histogram-based Analysis Method For The Detection And Diagnosis Of Neurodegenerative DiseasesApplication PCTUS2009064255Pending
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .